Cargando…
Statins and Neuropathic Pain: A Narrative Review
The frequently prescribed drug class of statins have pleiotropic effects and have been implicated in neuropathic pain syndromes. This narrative review examines studies of statin-induced neuropathic pain which to date have been conducted only in animal models. However, the pathophysiology of diabetic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203325/ https://www.ncbi.nlm.nih.gov/pubmed/32020545 http://dx.doi.org/10.1007/s40122-020-00153-9 |
_version_ | 1783529853380722688 |
---|---|
author | Pergolizzi, Joseph V. Magnusson, Peter LeQuang, Jo Ann Razmi, Robin Zampogna, Gianpietro Taylor, Robert |
author_facet | Pergolizzi, Joseph V. Magnusson, Peter LeQuang, Jo Ann Razmi, Robin Zampogna, Gianpietro Taylor, Robert |
author_sort | Pergolizzi, Joseph V. |
collection | PubMed |
description | The frequently prescribed drug class of statins have pleiotropic effects and have been implicated in neuropathic pain syndromes. This narrative review examines studies of statin-induced neuropathic pain which to date have been conducted only in animal models. However, the pathophysiology of diabetic neuropathy in humans may shed some light on the etiology of neuropathic pain. Statins have exhibited a paradoxical effect in that statins appear to reduce neuropathic pain in animals but have been associated with neuropathic pain in humans. While there are certain postulated mechanisms offering elucidation as to how statins might be associated with neuropathic pain, there is, as the American Heart Association stated, to date no definitive association between statins and neuropathic pain. Statins are important drugs that reduce cardiovascular risk factors and should be prescribed to appropriate patients with these risk factors but some of this population is also at elevated risk for neuropathic pain from other causes. |
format | Online Article Text |
id | pubmed-7203325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-72033252020-05-12 Statins and Neuropathic Pain: A Narrative Review Pergolizzi, Joseph V. Magnusson, Peter LeQuang, Jo Ann Razmi, Robin Zampogna, Gianpietro Taylor, Robert Pain Ther Review The frequently prescribed drug class of statins have pleiotropic effects and have been implicated in neuropathic pain syndromes. This narrative review examines studies of statin-induced neuropathic pain which to date have been conducted only in animal models. However, the pathophysiology of diabetic neuropathy in humans may shed some light on the etiology of neuropathic pain. Statins have exhibited a paradoxical effect in that statins appear to reduce neuropathic pain in animals but have been associated with neuropathic pain in humans. While there are certain postulated mechanisms offering elucidation as to how statins might be associated with neuropathic pain, there is, as the American Heart Association stated, to date no definitive association between statins and neuropathic pain. Statins are important drugs that reduce cardiovascular risk factors and should be prescribed to appropriate patients with these risk factors but some of this population is also at elevated risk for neuropathic pain from other causes. Springer Healthcare 2020-02-04 2020-06 /pmc/articles/PMC7203325/ /pubmed/32020545 http://dx.doi.org/10.1007/s40122-020-00153-9 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Review Pergolizzi, Joseph V. Magnusson, Peter LeQuang, Jo Ann Razmi, Robin Zampogna, Gianpietro Taylor, Robert Statins and Neuropathic Pain: A Narrative Review |
title | Statins and Neuropathic Pain: A Narrative Review |
title_full | Statins and Neuropathic Pain: A Narrative Review |
title_fullStr | Statins and Neuropathic Pain: A Narrative Review |
title_full_unstemmed | Statins and Neuropathic Pain: A Narrative Review |
title_short | Statins and Neuropathic Pain: A Narrative Review |
title_sort | statins and neuropathic pain: a narrative review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203325/ https://www.ncbi.nlm.nih.gov/pubmed/32020545 http://dx.doi.org/10.1007/s40122-020-00153-9 |
work_keys_str_mv | AT pergolizzijosephv statinsandneuropathicpainanarrativereview AT magnussonpeter statinsandneuropathicpainanarrativereview AT lequangjoann statinsandneuropathicpainanarrativereview AT razmirobin statinsandneuropathicpainanarrativereview AT zampognagianpietro statinsandneuropathicpainanarrativereview AT taylorrobert statinsandneuropathicpainanarrativereview |